Skip to content

For investors
Support
Webshop
Document portal

Diagnostic areas
Products
Services
Resources
About us

Contact us

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Post-transplantation
One Lambda Devyser Accept cfDNA
One Lambda Devyser Chimerism NGS

Thalassemia
Devyser Thalassemia NGS

Hereditary cancer
Devyser BRCA NGS
Devyser HBOC NGS
Devyser BRCA PALB2 NGS
Devyser LynchFAP

Fetal RHD screening NIPT
Devyser RHD

Cystic fibrosis
Devyser CFTR Core
Devyser CFTR 68
Devyser CFTR NGS
Devyser CFTR Italia

Cardiovascular diseases
Devyser Thrombophilia
Devyser FH NGS
Devyser HFE
Devyser CVD

Male infertility
Devyser AZF Extension
Devyser AZF v2

Rapid aneuploidy analysis
Devyser Compact
Devyser Complete
Devyser Extend
Devyser Resolution 13
Devyser Resolution 18
Devyser Resolution 21
Devyser Resolution XY

Software
Advyser Solid organs
Advyser Chimerism
Amplicon Suite

Accessories
560 sizer orange
DEV-5 Dye set
Devyser Index plate A
Devyser Index plate LB-A
Devyser library clean

Devyser Genomic Laboratories

Events & webinars
IVDR
Knowledge hub
Whitepapers
Devyser blog
Frequently asked questions (FAQs)
Calculator for chimerism
Sequence coverage calculator
IFUs and certificates

Our company
Investors
Distributors
News and press
Career
Contact us

Diagnostic areas

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Products

Post-transplantation
- One Lambda Devyser Accept cfDNA
- One Lambda Devyser Chimerism NGS
Thalassemia
- Devyser Thalassemia NGS
Hereditary cancer
Fetal RHD screening NIPT
- Devyser RHD
Cystic fibrosis
Cardiovascular diseases
Male infertility
- Devyser AZF Extension
- Devyser AZF v2
Rapid aneuploidy analysis
Software
Accessories

Services

Devyser Genomic Laboratories

Resources

Events & webinars
IVDR
Knowledge hub
Whitepapers
Devyser blog
Frequently asked questions (FAQs)
Calculator for chimerism
Sequence coverage calculator
IFUs and certificates

About us

Our company
Investors
Distributors
News and press
Career
Contact us

For investors
Support
Webshop
Document portal

The Devyser blog

Cystic fibrosis | March 18, 2024

Devyser CFTR 68 provides NHS Scotland with trustworthy, rapid results

We spoke with Dr. Andrew Purvis, Clinical Scientist for West of Scotland Centre for Genomic Medicine, in Glasgow, to talk about the impact of implementing Devyser CFTR 68 in an NHS Scotland Genomics...

Find out more

Filter

Cystic fibrosis

Devyser achieves breakthrough in the US with cystic fibrosis NGS test

Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...

The utility of broader CFTR genotyping in cystic fibrosis populations

On October 26th, we hosted an insightful webinar by Prof. Milan Macek (M.D., DSc.), where he...

Revised guidelines for cystic fibrosis carrier screening: The American College of Medical Genetics and Genomics (ACMG) expands CFTR screening recommendations

The American College of Medical Genetics and Genomics (ACMG) has released an updated position...

Simplify your lab workflow with single-tube NGS library preparation method

As a lab manager, you know the importance of streamlining workflows to maximize productivity and...

Clinical trials highlight the importance of correct CFTR mutation detection in cystic fibrosis patients

Cystic fibrosis is one of the most common genetic disorders. The disease is caused by mutations...

Diagnostic areas

Post-transplantation
Oncology
Hematology
Reproductive health
Cystic fibrosis
Cardiovascular diseases

Products and services

Kits and reagents
Our services

Resources

Events & webinars
Knowledge hub
Whitepapers
Devyser blog
Calculator for Chimerism
Sequence coverage calculator
IFUs and certificates

About us

Our company
Contact us
Distributors
News and press
Career
Whistleblowing policy

Investors

Press releases
Reports

© Devyser 2024

Privacy policy | Legal terms | About cookies